Innovative, high-quality medical education for clinicians in cardiology and other specialties.
Targeting CKD-aP at the Source: Key Mechanisms and Treatments
Steven Fishbane, MD
Maurizio Gallieni, MD
Navigating KDIGO Practice Guideline Recommendations to Maximize Proteinuria Reduction in Patients With IgAN
Chee Kay Cheung, MBChB, MRCP, PhD
Claudia Seikrit, MD
Case-Based Approach: Managing Hyperkalemia in Patients With CKD and Heart Failure
Ellie Kelepouris, MD, FACP, FAHA
Nihar R. Desai, MD, MPH
The Potassium Shift: Individualizing Hyperkalemia Management With Modern Oral Potassium Binders
James Burton, DM, FRCP
Pauline A. Swift, PhD
The Unmet Need in ASCVD: Why Targets Are Still Not Enough
Erin Michos
Obicetrapib: Mechanism Meets Clinical Impact
Christie Ballantyne, MD
Efficacy and Safety Deep Dive What Latest Data Tell Us
Advancing Lipid Care: CETP Inhibition and Overcoming Inertia in Modern ASCVD Management
Philip Scheltens, MD, PhD
Beyond LDL-C: Genetic Drivers of Residual Risk in ASCVD
CKD, Diabetes, and Albuminuria: Keeping Kidney-Protective Therapy on Board Despite Hyperkalemia
Differentiating Oral Potassium Binders: Mechanism, Onset, and Sodium Load
Hyperkalemia as a Barrier to GDMT: Why “Stopping GDMT” Is Often the Wrong Reflex